{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:08:12Z","timestamp":1792638492757,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41579-025-01271-x","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T10:56:29Z","timestamp":1768215389000},"page":"408-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The gut microbiome in solid-organ and haematopoietic-stem-cell transplantation"],"prefix":"10.1038","volume":"24","author":[{"given":"J. Casper","family":"Swarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes R.","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-7371","authenticated-orcid":false,"given":"Rinse K.","family":"Weersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"1271_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccc.2018.08.011","volume":"35","author":"A Sen","year":"2019","unstructured":"Sen, A., Callisen, H., Libricz, S. & Patel, B. Complications of solid organ transplantation: cardiovascular, neurologic, renal, and gastrointestinal. Crit. Care Clin. 35, 169\u2013186 (2019).","journal-title":"Crit. Care Clin."},{"key":"1271_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.21037\/atm.2018.09.68","volume":"6","author":"CK Black","year":"2018","unstructured":"Black, C. K., Termanini, K. M., Aguirre, O., Hawksworth, J. S. & Sosin, M. Solid organ transplantation in the 21st century. Ann. Transl. Med. 6, 409 (2018).","journal-title":"Ann. Transl. Med."},{"key":"1271_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1586\/ehm.11.39","volume":"4","author":"S Bhatia","year":"2011","unstructured":"Bhatia, S. Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Rev. Hematol. 4, 437\u2013452 (2011).","journal-title":"Expert Rev. Hematol."},{"key":"1271_CR4","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1007\/s10620-023-08012-1","volume":"68","author":"LD Ferreira","year":"2023","unstructured":"Ferreira, L. D. et al. Survival benefit of solid-organ transplantation: 10-year update. Dig. Dis. Sci. 68, 3810\u20133817 (2023).","journal-title":"Dig. Dis. Sci."},{"key":"1271_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/jha2.842","volume":"5","author":"BL Gr\u00f8nvold","year":"2024","unstructured":"Gr\u00f8nvold, B. L. et al. Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors. EJHaem 5, 117\u2013124 (2024).","journal-title":"EJHaem"},{"key":"1271_CR6","first-page":"204993612110390","volume":"8","author":"MS Rahi","year":"2021","unstructured":"Rahi, M. S. et al. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management. Ther. Adv. Infect. Dis. 8, 20499361211039050 (2021).","journal-title":"Ther. Adv. Infect. Dis."},{"key":"1271_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 7, 135 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1271_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn7566","volume":"14","author":"JC Swarte","year":"2022","unstructured":"Swarte, J. C. et al. Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation. Sci. Transl. Med. 14, eabn7566 (2022). This large-scale study characterize\u00a0post-transplantation gut microbiome of liver transplant recipients and kidney transplant recipients, and showed dysbiosis to be associated with transplantation outcomes.","journal-title":"Sci. Transl. Med."},{"key":"1271_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fmicb.2020.00301","volume":"11","author":"D Zhang","year":"2020","unstructured":"Zhang, D. et al. The cross-talk between gut microbiota and lungs in common lung diseases. Front. Microbiol. 11, 301 (2020).","journal-title":"Front. Microbiol."},{"key":"1271_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01312-23","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. The gut microbiome in end-stage lung disease and lung transplantation. mSystems 9, e0131223 (2024). This study demonstrates severe gut microbiome dysbiosis in patients with end-stage lung disease and in lung transplant recipients.","journal-title":"mSystems"},{"key":"1271_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jceh.2021.08.017","volume":"12","author":"N Farooqui","year":"2022","unstructured":"Farooqui, N., Elhence, A. & Shalimar A current understanding of bile acids in chronic liver disease. J. Clin. Exp. Hepatol. 12, 155\u2013173 (2022).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"1271_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236\u2013247 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","volume":"16","author":"Y Li","year":"2017","unstructured":"Li, Y., Tang, R., Leung, P. S. C., Gershwin, M. E. & Ma, X. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun. Rev. 16, 885\u2013896 (2017).","journal-title":"Autoimmun. Rev."},{"key":"1271_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41579-022-00821-x","volume":"21","author":"JG Natalini","year":"2023","unstructured":"Natalini, J. G., Singh, S. & Segal, L. N. The dynamic lung microbiome in health and disease. Nat. Rev. Microbiol. 21, 222\u2013235 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ehf2.12155","volume":"4","author":"M Luedde","year":"2017","unstructured":"Luedde, M. et al. Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Fail. 4, 282\u2013290 (2017).","journal-title":"ESC Heart Fail."},{"key":"1271_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174099","volume":"12","author":"T Kamo","year":"2017","unstructured":"Kamo, T. et al. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS ONE 12, e0174099 (2017).","journal-title":"PLoS ONE"},{"key":"1271_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/1541-7786.MCR-23-0080","volume":"22","author":"N Hussein","year":"2024","unstructured":"Hussein, N., Rajasuriar, R., Khan, A. M., Lim, Y. A.-L. & Gan, G. G. The role of the gut microbiome in hematological cancers. Mol. Cancer Res. 22, 7\u201320 (2024).","journal-title":"Mol. Cancer Res."},{"key":"1271_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu, C. L. & Schnabl, B. The gut\u2013liver axis and gut microbiota in health and liver disease. Nat. Rev. Microbiol. 21, 719\u2013733 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03056-y","volume":"24","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease. Genome Biol. 24, 226 (2023).","journal-title":"Genome Biol."},{"key":"1271_CR21","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69, 2131\u20132142 (2020).","journal-title":"Gut"},{"key":"1271_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59\u201364 (2014).","journal-title":"Nature"},{"key":"1271_CR23","doi-asserted-by":"publisher","first-page":"1185787","DOI":"10.3389\/fmicb.2023.1185787","volume":"14","author":"P Guevara-Ram\u00edrez","year":"2023","unstructured":"Guevara-Ram\u00edrez, P. et al. Role of the gut microbiota in hematologic cancer. Front. Microbiol. 14, 1185787 (2023).","journal-title":"Front. Microbiol."},{"key":"1271_CR24","doi-asserted-by":"publisher","first-page":"21567","DOI":"10.1002\/cam4.6557","volume":"12","author":"L Qi","year":"2023","unstructured":"Qi, L. et al. Longitudinal dynamics of gut microbiota in the pathogenesis of acute graft-versus-host disease. Cancer Med. 12, 21567\u201321578 (2023).","journal-title":"Cancer Med."},{"key":"1271_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc.2018.10","volume":"18","author":"Y Shono","year":"2018","unstructured":"Shono, Y. & van den Brink, M. R. M. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat. Rev. Cancer 18, 283\u2013295 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1271_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1124\/dmd.118.084772","volume":"47","author":"Y Guo","year":"2019","unstructured":"Guo, Y. et al. Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites. Drug Metab. Dispos. 47, 194\u2013202 (2019).","journal-title":"Drug Metab. Dispos."},{"key":"1271_CR27","doi-asserted-by":"publisher","unstructured":"Baghai Arassi, M. et al. Unraveling interindividual differences and functional consequences of gut microbial metabolism of immunosuppressants. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.03.28.586928 (2024).","DOI":"10.1101\/2024.03.28.586928"},{"key":"1271_CR28","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1021\/acschembio.2c00312","volume":"17","author":"L Qian","year":"2022","unstructured":"Qian, L. et al. Identification of gut bacterial enzymes for keto-reductive metabolism of xenobiotics. ACS Chem. Biol. 17, 1665\u20131671 (2022).","journal-title":"ACS Chem. Biol."},{"key":"1271_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-025-02142-6","volume":"13","author":"OM Drevland","year":"2025","unstructured":"Drevland, O. M. et al. Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipients. Microbiome 13, 169 (2025).","journal-title":"Microbiome"},{"key":"1271_CR30","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1158\/1078-0432.CCR-24-0875","volume":"30","author":"A Rashidi","year":"2024","unstructured":"Rashidi, A. et al. Oral and gut microbiome alterations in oral chronic GVHD disease: results from close assessment and testing for chronic GVHD (CATCH study). Clin. Cancer Res. 30, 4240\u20134250 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1271_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740\u2013748 (2016).","journal-title":"Gut"},{"key":"1271_CR32","first-page":"386","volume":"9","author":"JC Swarte","year":"2020","unstructured":"Swarte, J. C. et al. Characteristics and dysbiosis of the gut microbiome in renal transplant recipients. J. Clin. Med. Res. 9, 386 (2020).","journal-title":"J. Clin. Med. Res."},{"key":"1271_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12633-4","volume":"10","author":"MK Annavajhala","year":"2019","unstructured":"Annavajhala, M. K. et al. Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation. Nat. Commun. 10, 4715 (2019). This article provides longitudinal evidence that liver transplant recipients develop multidrug-resistant gut colonization, which links dysbiosis with risk of infection.","journal-title":"Nat. Commun."},{"key":"1271_CR34","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.3748\/wjg.v27.i45.7792","volume":"27","author":"L Bastard","year":"2021","unstructured":"Bastard, L., Chevallier, Q. & Montassier, P. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft host disease. World J. Gastroenterol. 27, 7792\u20137800 (2021).","journal-title":"World J. Gastroenterol."},{"key":"1271_CR35","doi-asserted-by":"publisher","first-page":"7244","DOI":"10.1182\/blood-2023-189071","volume":"142","author":"D Lan","year":"2023","unstructured":"Lan, D., Xiong, J.-K., Zhang, C. & Zhang, X. Association between gut microbiota and leukemia: a bidirectional multivariable mendelian randomization study. Blood 142, 7244\u20137244 (2023).","journal-title":"Blood"},{"key":"1271_CR36","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled, J. U. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 382, 822\u2013834 (2020). This article demonstrates that gut microbiome diversity is a strong predictor of survival after allogeneic haematopoietic-stem-cell transplantation and establishes clinical significance of gut microbiome diversity in haematology.","journal-title":"N. Engl. J. Med."},{"key":"1271_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/cis580","volume":"55","author":"Y Taur","year":"2012","unstructured":"Taur, Y. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55, 905\u2013914 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"1271_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13467-w","volume":"10","author":"M Magruder","year":"2019","unstructured":"Magruder, M. et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat. Commun. 10, 5521 (2019). This study shows that gut abundance of uropathogens predicts post-transplant urinary tract infections, thereby illustrating translational biomarker potential.","journal-title":"Nat. Commun."},{"key":"1271_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.chom.2023.11.016","volume":"32","author":"CJ Lehmann","year":"2024","unstructured":"Lehmann, C. J. et al. Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe 32, 117\u2013130.e4 (2024).","journal-title":"Cell Host Microbe"},{"key":"1271_CR40","doi-asserted-by":"publisher","first-page":"dlae152","DOI":"10.1093\/jacamr\/dlae152","volume":"6","author":"AJ Liu","year":"2024","unstructured":"Liu, A. J., Dennis, A. S. M., Fariha, Z., Pai Mangalore, R. & Macesic, N. Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review. JAC Antimicrob. Resist. 6, dlae152 (2024).","journal-title":"JAC Antimicrob. Resist."},{"key":"1271_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mib.2018.04.004","volume":"45","author":"KL Wyres","year":"2018","unstructured":"Wyres, K. L. & Holt, K. E. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr. Opin. Microbiol. 45, 131\u2013139 (2018).","journal-title":"Curr. Opin. Microbiol."},{"key":"1271_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias, C. A. & Murray, B. E. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10, 266\u2013278 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/jiad033","volume":"228","author":"JC N\u00f8rgaard","year":"2023","unstructured":"N\u00f8rgaard, J. C. et al. Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients. J. Infect. Dis. 228, 28\u201336 (2023).","journal-title":"J. Infect. Dis."},{"key":"1271_CR44","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s42003-022-03887-8","volume":"5","author":"D Dai","year":"2022","unstructured":"Dai, D. et al. Integrated multi-omics reveal important roles of gut contents in intestinal ischemia-reperfusion induced injuries in rats. Commun. Biol. 5, 938 (2022).","journal-title":"Commun. Biol."},{"key":"1271_CR45","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1172\/JCI127550","volume":"129","author":"K Nakamura","year":"2019","unstructured":"Nakamura, K. et al. Antibiotic pretreatment alleviates liver transplant damage in mice and humans. J. Clin. Invest. 129, 3420\u20133434 (2019).","journal-title":"J. Clin. Invest."},{"key":"1271_CR46","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/lt.25633","volume":"25","author":"T Ito","year":"2019","unstructured":"Ito, T. et al. Impact of rifaximin therapy on ischemia\/reperfusion injury in liver transplantation: a propensity score-matched analysis. Liver Transpl. 25, 1778\u20131789 (2019).","journal-title":"Liver Transpl."},{"key":"1271_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jim-2020-001715","volume":"70","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. Quantitative increase in short-chain fatty acids, especially butyrate protects kidney from ischemia\/reperfusion injury. J. Invest. Med. 70, 29\u201335 (2022).","journal-title":"J. Invest. Med."},{"key":"1271_CR48","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.medmic.2024.100106","volume":"20","author":"RH Lathakumari","year":"2024","unstructured":"Lathakumari, R. H., Vajravelu, L. K., Satheesan, A., Ravi, S. & Thulukanam, J. Antibiotics and the gut microbiome: understanding the impact on human health. Med. Microecol. 20, 100106 (2024).","journal-title":"Med. Microecol."},{"key":"1271_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jare.2023.11.027","volume":"64","author":"S Li","year":"2024","unstructured":"Li, S., Zhu, S. & Yu, J. The role of gut microbiota and metabolites in cancer chemotherapy. J. Adv. Res. 64, 223\u2013235 (2024).","journal-title":"J. Adv. Res."},{"key":"1271_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01735-9","volume":"16","author":"J Liu","year":"2021","unstructured":"Liu, J., Liu, C. & Yue, J. Radiotherapy and the gut microbiome: facts and fiction. Radiat. Oncol. 16, 9 (2021).","journal-title":"Radiat. Oncol."},{"key":"1271_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"AV Vila","year":"2020","unstructured":"Vila, A. V. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 11, 362 (2020).","journal-title":"Nat. Commun."},{"key":"1271_CR52","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462\u2013467 (2019).","journal-title":"Nature"},{"key":"1271_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"1271_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10123-020-00129-x","volume":"23","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Jiang, X. & Chu, W. Shifts in the gut microbiota of mice in response to dexamethasone administration. Int. Microbiol. 23, 565\u2013573 (2020).","journal-title":"Int. Microbiol."},{"key":"1271_CR55","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/MIB.0000000000000332","volume":"21","author":"EY Huang","year":"2015","unstructured":"Huang, E. Y. et al. Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases. Inflamm. Bowel Dis. 21, 963\u2013972 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"1271_CR56","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41579-023-00933-y","volume":"21","author":"SRS Fishbein","year":"2023","unstructured":"Fishbein, S. R. S., Mahmud, B. & Dantas, G. Antibiotic perturbations to the gut microbiome. Nat. Rev. Microbiol. 21, 772\u2013788 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR57","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","volume":"20","author":"E Holler","year":"2014","unstructured":"Holler, E. et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol. Blood Marrow Transpl. 20, 640\u2013645 (2014).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"1271_CR58","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.aax3760","volume":"366","author":"CK Stein-Thoeringer","year":"2019","unstructured":"Stein-Thoeringer, C. K. et al. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 366, 1143\u20131149 (2019).","journal-title":"Science"},{"key":"1271_CR59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas, D. et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 10, 277 (2019).","journal-title":"Front. Immunol."},{"key":"1271_CR60","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492\u2013506 (2020).","journal-title":"Cell Res."},{"key":"1271_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105\u2013108 (2011).","journal-title":"Science"},{"key":"1271_CR62","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"1271_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3920\/BM2020.0057","volume":"11","author":"EE Blaak","year":"2020","unstructured":"Blaak, E. E. et al. Short chain fatty acids in human gut and metabolic health. Benef. Microbes 11, 411\u2013455 (2020).","journal-title":"Benef. Microbes"},{"key":"1271_CR64","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1053\/j.jrn.2023.07.001","volume":"33","author":"ST Stoler","year":"2023","unstructured":"Stoler, S. T., Chan, M. & Chadban, S. J. Nutrition in the management of kidney transplant recipients. J. Ren. Nutr. 33, S67\u2013S72 (2023).","journal-title":"J. Ren. Nutr."},{"key":"1271_CR65","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fmed.2018.00302","volume":"5","author":"JV Nolte Fong","year":"2018","unstructured":"Nolte Fong, J. V. & Moore, L. W. Nutrition trends in kidney transplant recipients: the importance of dietary monitoring and need for evidence-based recommendations. Front. Med. 5, 302 (2018).","journal-title":"Front. Med."},{"key":"1271_CR66","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/ndt\/gfab232","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Mapping health-related quality of life after kidney transplantation by group comparisons: a systematic review. Nephrol. Dial. Transpl. 36, 2327\u20132339 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1271_CR67","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F. et al. The microbiota\u2013gut\u2013brain axis. Physiol. Rev. 99, 1877\u20132013 (2019).","journal-title":"Physiol. Rev."},{"key":"1271_CR68","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1038\/s41380-023-02146-4","volume":"28","author":"D Mulder","year":"2023","unstructured":"Mulder, D., Aarts, E., Arias Vasquez, A. & Bloemendaal, M. A systematic review exploring the association between the human gut microbiota and brain connectivity in health and disease. Mol. Psychiatry 28, 5037\u20135061 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1271_CR69","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623\u2013632 (2019).","journal-title":"Nat. Microbiol."},{"key":"1271_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43431-8","volume":"14","author":"JC Swarte","year":"2023","unstructured":"Swarte, J. C. et al. Health-related quality of life is linked to the gut microbiome in kidney transplant recipients. Nat. Commun. 14, 7968 (2023). This paper links health-related quality of life to the gut microbiome in kidney transplant recipients, thereby showing the clinical relevance of the observed dysbiosis.","journal-title":"Nat. Commun."},{"key":"1271_CR71","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/lt.24754","volume":"23","author":"JS Bajaj","year":"2017","unstructured":"Bajaj, J. S. et al. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. Liver Transpl. 23, 907\u2013914 (2017).","journal-title":"Liver Transpl."},{"key":"1271_CR72","first-page":"2978","volume":"131","author":"BW Haak","year":"2018","unstructured":"Haak, B. W. et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood 131, 2978\u20132986 (2018). This paper reveals that butyrate-producing taxa protect against viral infections in allogeneic haematopoietic-stem-cell transplantation, thereby providing mechanistic links between metabolites and immunity.","journal-title":"Blood"},{"key":"1271_CR73","doi-asserted-by":"publisher","first-page":"e4627","DOI":"10.1093\/cid\/ciaa068","volume":"73","author":"I Stoma","year":"2021","unstructured":"Stoma, I. et al. Compositional flux within the intestinal microbiota and risk for bloodstream infection with Gram-negative bacteria. Clin. Infect. Dis. 73, e4627\u2013e4635 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1271_CR74","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41392-023-01515-3","volume":"8","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort study. Signal Transduct. Target. Ther. 8, 326 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1271_CR75","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.3390\/jcm11154365","volume":"11","author":"S Dudzicz-Gojowy","year":"2022","unstructured":"Dudzicz-Gojowy, S., Wi\u0119cek, A. & Adamczak, M. Clostridioides difficile infection in patients after organ transplantation \u2014 a narrative overview. J. Clin. Med. 11, 4365 (2022).","journal-title":"J. Clin. Med."},{"key":"1271_CR76","first-page":"697","volume":"98","author":"JR Lee","year":"2014","unstructured":"Lee, J. R. et al. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation 98, 697\u2013705 (2014). An early study describing associations between gut microbiota composition and clinical complications in kidney transplantation.","journal-title":"Transplantation"},{"key":"1271_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76072-8","volume":"10","author":"JE Kim","year":"2020","unstructured":"Kim, J. E. et al. Effect of the similarity of gut microbiota composition between donor and recipient on graft function after living donor kidney transplantation. Sci. Rep. 10, 18881 (2020).","journal-title":"Sci. Rep."},{"key":"1271_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0474-8","volume":"6","author":"CM McIntosh","year":"2018","unstructured":"McIntosh, C. M., Chen, L., Shaiber, A., Eren, A. M. & Alegre, M.-L. Gut microbes contribute to variation in solid organ transplant outcomes in mice. Microbiome 6, 96 (2018).","journal-title":"Microbiome"},{"key":"1271_CR79","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1200\/JCO.2016.70.3348","volume":"35","author":"JU Peled","year":"2017","unstructured":"Peled, J. U. et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J. Clin. Oncol. 35, 1650\u20131659 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1271_CR80","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/ajt.14661","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. Am. J. Transplant. 18, 1646\u20131656 (2018).","journal-title":"Am. J. Transplant."},{"key":"1271_CR81","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1182\/blood.2021014255","volume":"139","author":"O Miltiadous","year":"2022","unstructured":"Miltiadous, O. et al. Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant. Blood 139, 2758\u20132769 (2022).","journal-title":"Blood"},{"key":"1271_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01100-2","volume":"9","author":"AC Ingham","year":"2021","unstructured":"Ingham, A. C. et al. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Microbiome 9, 148 (2021).","journal-title":"Microbiome"},{"key":"1271_CR83","doi-asserted-by":"publisher","first-page":"339ra71","DOI":"10.1126\/scitranslmed.aaf2311","volume":"8","author":"Y Shono","year":"2016","unstructured":"Shono, Y. et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci. Transl. Med. 8, 339ra71 (2016).","journal-title":"Sci. Transl. Med."},{"key":"1271_CR84","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.chom.2024.08.004","volume":"32","author":"E Hayase","year":"2024","unstructured":"Hayase, E. et al. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe 32, 1621\u20131636.e6 (2024).","journal-title":"Cell Host Microbe"},{"key":"1271_CR85","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood.2021010719","volume":"139","author":"MD Docampo","year":"2022","unstructured":"Docampo, M. D. et al. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease. Blood 139, 2392\u20132405 (2022).","journal-title":"Blood"},{"key":"1271_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13498-3","volume":"10","author":"D Michonneau","year":"2019","unstructured":"Michonneau, D. et al. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat. Commun. 10, 5695 (2019).","journal-title":"Nat. Commun."},{"key":"1271_CR87","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41564-024-01617-w","volume":"9","author":"S Lindner","year":"2024","unstructured":"Lindner, S. et al. Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease. Nat. Microbiol. 9, 614\u2013630 (2024).","journal-title":"Nat. Microbiol."},{"key":"1271_CR88","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3324\/haematol.2022.281309","volume":"108","author":"S Chhabra","year":"2023","unstructured":"Chhabra, S. et al. Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination. Haematologica 108, 250\u2013256 (2023).","journal-title":"Haematologica"},{"key":"1271_CR89","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41392-023-01377-9","volume":"8","author":"Q Li","year":"2023","unstructured":"Li, Q. & Lan, P. Activation of immune signals during organ transplantation. Signal Transduct. Target. Ther. 8, 110 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1271_CR90","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ajt.2025.02.010","volume":"25","author":"J Holle","year":"2025","unstructured":"Holle, J. et al. Gut microbiome alterations precede graft rejection in kidney transplantation patients. Am. J. Transpl. 25, 1643\u20131656 (2025).","journal-title":"Am. J. Transpl."},{"key":"1271_CR91","doi-asserted-by":"publisher","first-page":"2102885","DOI":"10.1080\/19490976.2022.2102885","volume":"14","author":"SK Lee","year":"2022","unstructured":"Lee, S. K. et al. A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients. Gut Microbes 14, 2102885 (2022).","journal-title":"Gut Microbes"},{"key":"1271_CR92","doi-asserted-by":"publisher","first-page":"646831","DOI":"10.3389\/fimmu.2021.646831","volume":"12","author":"F Qiu","year":"2021","unstructured":"Qiu, F. et al. Berberine promotes induction of immunological tolerance to an allograft via downregulating memory CD8+ T-cells through altering the gut microbiota. Front. Immunol. 12, 646831 (2021).","journal-title":"Front. Immunol."},{"key":"1271_CR93","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1097\/TP.0000000000004161","volume":"106","author":"KM Rey","year":"2022","unstructured":"Rey, K. M. et al. Dysbiosis of the female murine gut microbiome exacerbates neutrophil-mediated vascular allograft injury by affecting immunoregulation by acetate. Transplantation 106, 2155\u20132165 (2022).","journal-title":"Transplantation"},{"key":"1271_CR94","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142528","volume":"5","author":"JS Bromberg","year":"2020","unstructured":"Bromberg, J. S. et al. Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes. JCI Insight 5, e142528 (2020).","journal-title":"JCI Insight"},{"key":"1271_CR95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17460913.2024.2417608","volume":"20","author":"H Yan","year":"2025","unstructured":"Yan, H. et al. Causal associations between gut Bifidobacteriaceae and transplant failure: a Mendelian randomization study. Future Microbiol. 20, 23\u201331 (2025).","journal-title":"Future Microbiol."},{"key":"1271_CR96","doi-asserted-by":"publisher","first-page":"873607","DOI":"10.3389\/fimmu.2022.873607","volume":"13","author":"N Garabatos","year":"2022","unstructured":"Garabatos, N. & Santamaria, P. Gut microbial antigenic mimicry in autoimmunity. Front. Immunol. 13, 873607 (2022).","journal-title":"Front. Immunol."},{"key":"1271_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22962-y","volume":"12","author":"A Salosensaari","year":"2021","unstructured":"Salosensaari, A. et al. Taxonomic signatures of cause-specific mortality risk in human gut microbiome. Nat. Commun. 12, 2671 (2021).","journal-title":"Nat. Commun."},{"key":"1271_CR98","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1182\/blood.2020006923","volume":"137","author":"N Khan","year":"2021","unstructured":"Khan, N. et al. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood 137, 1527\u20131537 (2021).","journal-title":"Blood"},{"key":"1271_CR99","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/cid\/ciab1043","volume":"78","author":"JA Messina","year":"2021","unstructured":"Messina, J. A. et al. Enterococcus intestinal domination is associated with increased mortality in the acute leukemia chemotherapy population. Clin. Infect. Dis. 78, 414\u2013422 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1271_CR100","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1182\/blood.2021015352","volume":"140","author":"M Burgos da Silva","year":"2022","unstructured":"Burgos da Silva, M. et al. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease. Blood 140, 2385\u20132397 (2022).","journal-title":"Blood"},{"key":"1271_CR101","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/gutjnl-2023-331441","volume":"73","author":"JC Swarte","year":"2024","unstructured":"Swarte, J. C. et al. Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients. Gut 73, 1650\u20131661 (2024). This article shows that multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid-organ transplant recipients, including liver, kidney, lung and heart transplant recipients.","journal-title":"Gut"},{"key":"1271_CR102","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1053\/j.gastro.2025.04.025","volume":"169","author":"LA Bolte","year":"2025","unstructured":"Bolte, L. A., Bj\u00f6rk, J. R., Gacesa, R. & Weersma, R. K. Pharmacomicrobiomics: the role of the gut microbiome in immunomodulation and cancer therapy. Gastroenterology 169, 813\u2013827 (2025).","journal-title":"Gastroenterology"},{"key":"1271_CR103","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/tpj.2017.49","volume":"18","author":"WS Oetting","year":"2018","unstructured":"Oetting, W. S. et al. Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients. Pharmacogenom. J. 18, 501\u2013505 (2018).","journal-title":"Pharmacogenom. J."},{"key":"1271_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122399","volume":"10","author":"JR Lee","year":"2015","unstructured":"Lee, J. R. et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS ONE 10, e0122399 (2015).","journal-title":"PLoS ONE"},{"key":"1271_CR105","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1124\/dmd.111.039040","volume":"39","author":"I Laverdi\u00e8re","year":"2011","unstructured":"Laverdi\u00e8re, I., Caron, P., Harvey, M., L\u00e9vesque, \u00c9 & Guillemette, C. In vitro investigation of human UDP-glucuronosyltransferase isoforms responsible for tacrolimus glucuronidation: predominant contribution of UGT1A4. Drug Metab. Dispos. 39, 1127\u20131130 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"1271_CR106","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.chroma.2016.10.075","volume":"1475","author":"C Tron","year":"2016","unstructured":"Tron, C. et al. A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients. J. Chromatogr. A 1475, 55\u201363 (2016).","journal-title":"J. Chromatogr. A"},{"key":"1271_CR107","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.phrs.2017.03.027","volume":"124","author":"C Tron","year":"2017","unstructured":"Tron, C. et al. Tacrolimus: does direct glucuronidation matter? An analytical and pharmacological perspective. Pharmacol. Res. 124, 164\u2013166 (2017).","journal-title":"Pharmacol. Res."},{"key":"1271_CR108","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","volume":"181","author":"B Javdan","year":"2020","unstructured":"Javdan, B. et al. Personalized mapping of drug metabolism by the human gut microbiome. Cell 181, 1661\u20131679.e22 (2020).","journal-title":"Cell"},{"key":"1271_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","volume":"46","author":"CE Staatz","year":"2007","unstructured":"Staatz, C. E. & Tett, S. E. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin. Pharmacokinet. 46, 13\u201358 (2007).","journal-title":"Clin. Pharmacokinet."},{"key":"1271_CR110","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/phar.2724","volume":"42","author":"L Braghieri","year":"2022","unstructured":"Braghieri, L. et al. Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2\u2009g versus 3\u2009g daily early after heart transplantation. Pharmacotherapy 42, 697\u2013706 (2022).","journal-title":"Pharmacotherapy"},{"key":"1271_CR111","doi-asserted-by":"publisher","first-page":"eaax2358","DOI":"10.1126\/sciadv.aax2358","volume":"5","author":"MR Taylor","year":"2019","unstructured":"Taylor, M. R. et al. Vancomycin relieves mycophenolate mofetil\u2013induced gastrointestinal toxicity by eliminating gut bacterial \u03b2-glucuronidase activity. Sci. Adv. 5, eaax2358 (2019).","journal-title":"Sci. Adv."},{"key":"1271_CR112","doi-asserted-by":"publisher","first-page":"122792","DOI":"10.1016\/j.lfs.2024.122792","volume":"351","author":"C Brossier","year":"2024","unstructured":"Brossier, C. et al. Gut microbiota biotransformation of drug glucuronides leading to gastrointestinal toxicity: therapeutic potential of bacterial \u03b2-glucuronidase inhibition in mycophenolate-induced enteropathy. Life Sci. 351, 122792 (2024).","journal-title":"Life Sci."},{"key":"1271_CR113","doi-asserted-by":"publisher","first-page":"1032290","DOI":"10.3389\/fmicb.2022.1032290","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats. Front. Microbiol. 13, 1032290 (2022).","journal-title":"Front. Microbiol."},{"key":"1271_CR114","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/TP.0000000000003494","volume":"105","author":"Y Han","year":"2021","unstructured":"Han, Y. et al. Intestinal dysbiosis correlates with sirolimus-induced metabolic disorders in mice. Transplantation 105, 1017\u20131029 (2021).","journal-title":"Transplantation"},{"key":"1271_CR115","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41591-025-03615-9","volume":"31","author":"JA Gilbert","year":"2025","unstructured":"Gilbert, J. A. et al. Clinical translation of microbiome research. Nat. Med. 31, 1099\u20131113 (2025).","journal-title":"Nat. Med."},{"key":"1271_CR116","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","volume":"604","author":"R Gacesa","year":"2022","unstructured":"Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732\u2013739 (2022).","journal-title":"Nature"},{"key":"1271_CR117","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","volume":"22","author":"FC Ross","year":"2024","unstructured":"Ross, F. C. et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat. Rev. Microbiol. 22, 671\u2013686 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"1271_CR118","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bjh.16218","volume":"188","author":"S Andersen","year":"2020","unstructured":"Andersen, S. et al. Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogeneic transplantation. Br. J. Haematol. 188, 570\u2013581 (2020).","journal-title":"Br. J. Haematol."},{"key":"1271_CR119","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/nu11122958","volume":"11","author":"F D\u2019Amico","year":"2019","unstructured":"D\u2019Amico, F. et al. Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis. Nutrients 11, 2958 (2019).","journal-title":"Nutrients"},{"key":"1271_CR120","first-page":"101","volume":"7","author":"S Kaundal","year":"2024","unstructured":"Kaundal, S. et al. A role for diet and gut microbiota metabolites in autologous hematopoietic cell transplant recipients. Blood Cell Ther. 7, 101\u2013105 (2024).","journal-title":"Blood Cell Ther."},{"key":"1271_CR121","doi-asserted-by":"publisher","first-page":"55","DOI":"10.6002\/ect.2011.0082","volume":"10","author":"B Tavil","year":"2012","unstructured":"Tavil, B., Koksal, E., Yalcin, S. S. & Uckan, D. Pretransplant nutritional habits and clinical outcome in children undergoing hematopoietic stem cell transplant. Exp. Clin. Transplant. 10, 55\u201361 (2012).","journal-title":"Exp. Clin. Transplant."},{"key":"1271_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403991","volume":"11","author":"W Hong","year":"2024","unstructured":"Hong, W. et al. Sterile diet causes gut microbiome collapse of cancer patients post hematopoietic cell transplantation, but normal diet recovers them. Adv. Sci. 11, e2403991 (2024).","journal-title":"Adv. Sci."},{"key":"1271_CR123","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1681\/ASN.2019080852","volume":"31","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Gut microbial metabolites induce donor-specific tolerance of kidney allografts through induction of T regulatory cells by short-chain fatty acids. J. Am. Soc. Nephrol. 31, 1445\u20131461 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1271_CR124","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2215\/CJN.06710619","volume":"15","author":"AW Gomes-Neto","year":"2020","unstructured":"Gomes-Neto, A. W. et al. Mediterranean style diet and kidney function loss in kidney transplant recipients. Clin. J. Am. Soc. Nephrol. 15, 238\u2013246 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1271_CR125","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/nu13010007","volume":"13","author":"G Merra","year":"2020","unstructured":"Merra, G. et al. Influence of Mediterranean diet on human gut microbiota. Nutrients 13, 7 (2020).","journal-title":"Nutrients"},{"key":"1271_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01469-2","volume":"11","author":"I Bourdeau-Julien","year":"2023","unstructured":"Bourdeau-Julien, I. et al. The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population. Microbiome 11, 26 (2023).","journal-title":"Microbiome"},{"key":"1271_CR127","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","volume":"70","author":"LA Bolte","year":"2021","unstructured":"Bolte, L. A. et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut 70, 1287\u20131298 (2021).","journal-title":"Gut"},{"key":"1271_CR128","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1159\/000368714","volume":"7","author":"S Iyama","year":"2014","unstructured":"Iyama, S. et al. Efficacy of enteral supplementation enriched with glutamine, fiber, and oligosaccharide on mucosal injury following hematopoietic stem cell transplantation. Case Rep. Oncol. 7, 692\u2013699 (2014).","journal-title":"Case Rep. Oncol."},{"key":"1271_CR129","doi-asserted-by":"publisher","first-page":"932.e1","DOI":"10.1016\/j.jtct.2021.07.009","volume":"27","author":"TM Andermann","year":"2021","unstructured":"Andermann, T. M. et al. A fructo-oligosaccharide prebiotic is well tolerated in adults undergoing allogeneic hematopoietic stem cell transplantation: a phase I dose-escalation trial. Transplant. Cell Ther. 27, 932.e1\u2013932.e11 (2021).","journal-title":"Transplant. Cell Ther."},{"key":"1271_CR130","doi-asserted-by":"publisher","first-page":"101836","DOI":"10.1016\/j.trim.2023.101836","volume":"78","author":"E Yazdandoust","year":"2023","unstructured":"Yazdandoust, E. et al. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation. Transpl. Immunol. 78, 101836 (2023).","journal-title":"Transpl. Immunol."},{"key":"1271_CR131","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1038\/s41591-023-02587-y","volume":"29","author":"MM Riwes","year":"2023","unstructured":"Riwes, M. M. et al. Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation. Nat. Med. 29, 2805\u20132813 (2023).","journal-title":"Nat. Med."},{"key":"1271_CR132","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.clnu.2024.11.022","volume":"44","author":"B Gardiner","year":"2025","unstructured":"Gardiner, B., Wardill, H. R., O\u2019Connor, G., Hargrave, D. & Lett, A. M. The impact of fibre and prebiotic interventions on outcomes in cancer and haematopoietic stem cell transplantation: a systematic review. Clin. Nutr. 44, 86\u2013100 (2025).","journal-title":"Clin. Nutr."},{"key":"1271_CR133","doi-asserted-by":"publisher","first-page":"S492","DOI":"10.1097\/01.tp.0000888084.43958.8b","volume":"106","author":"S Chan","year":"2022","unstructured":"Chan, S. et al. 426.6: Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study. Transplantation 106, S492\u2013S493 (2022).","journal-title":"Transplantation"},{"key":"1271_CR134","first-page":"CD014804","volume":"9","author":"TE Cooper","year":"2022","unstructured":"Cooper, T. E. et al. Synbiotics, prebiotics and probiotics for solid organ transplant recipients. Cochrane Database Syst. Rev. 9, CD014804 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1271_CR135","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","volume":"16","author":"ME Sanders","year":"2019","unstructured":"Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R. & Rastall, R. A. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol. 16, 605\u2013616 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1271_CR136","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043054","volume":"11","author":"C Goodman","year":"2021","unstructured":"Goodman, C., Keating, G., Georgousopoulou, E., Hespe, C. & Levett, K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open 11, e043054 (2021).","journal-title":"BMJ Open"},{"key":"1271_CR137","first-page":"CD005496","volume":"7","author":"S Sharif","year":"2023","unstructured":"Sharif, S., Meader, N., Oddie, S. J., Rojas-Reyes, M. X. & McGuire, W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst. Rev. 7, CD005496 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1271_CR138","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molmed.2024.12.005","volume":"31","author":"OP Vallejos","year":"2025","unstructured":"Vallejos, O. P., Bueno, S. M. & Kalergis, A. M. Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects. Trends Mol. Med. 31, 731\u2013742 (2025).","journal-title":"Trends Mol. Med."},{"key":"1271_CR139","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1182\/blood-2003-11-3769","volume":"103","author":"A Gerbitz","year":"2004","unstructured":"Gerbitz, A. et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103, 4365\u20134367 (2004).","journal-title":"Blood"},{"key":"1271_CR140","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.20112408","volume":"209","author":"RR Jenq","year":"2012","unstructured":"Jenq, R. R. et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J. Exp. Med. 209, 903\u2013911 (2012).","journal-title":"J. Exp. Med."},{"key":"1271_CR141","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00794-22","volume":"10","author":"X Miao","year":"2022","unstructured":"Miao, X. et al. Lactobacillus rhamnosus HN001 ameliorates BEZ235-induced intestinal dysbiosis and prolongs cardiac transplant survival. Microbiol. Spectr. 10, e0079422 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1271_CR142","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12947","volume":"31","author":"E Gorshein","year":"2017","unstructured":"Gorshein, E. et al. Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation. Clin. Transplant. 31, e12947 (2017).","journal-title":"Clin. Transplant."},{"key":"1271_CR143","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00595-024-02918-7","volume":"55","author":"S Yoshiya","year":"2025","unstructured":"Yoshiya, S. et al. The impact of perioperative synbiotics treatment in living-donor liver transplantation after induction of early enteral nutrition. Surg. Today 55, 475\u2013482 (2025).","journal-title":"Surg. Today"},{"key":"1271_CR144","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cgh.2015.05.027","volume":"13","author":"T Sawas","year":"2015","unstructured":"Sawas, T., Al Halabi, S., Hernaez, R., Carey, W. D. & Cho, W. K. Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 13, 1567\u20131574.e3 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1271_CR145","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/07315724.2017.1334602","volume":"36","author":"B Guida","year":"2017","unstructured":"Guida, B. et al. Effect of a short-course treatment with synbiotics on plasma p-Cresol concentration in kidney transplant recipients. J. Am. Coll. Nutr. 36, 586\u2013591 (2017).","journal-title":"J. Am. Coll. Nutr."},{"key":"1271_CR146","doi-asserted-by":"publisher","first-page":"1153188","DOI":"10.3389\/fmicb.2023.1153188","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang, P., Chen, J., Ming, Y. & Niu, Y. Probiotics treatment ameliorated mycophenolic acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice. Front. Microbiol. 14, 1153188 (2023).","journal-title":"Front. Microbiol."},{"key":"1271_CR147","doi-asserted-by":"publisher","first-page":"1143548","DOI":"10.3389\/fimmu.2023.1143548","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials. Front. Immunol. 14, 1143548 (2023).","journal-title":"Front. Immunol."},{"key":"1271_CR148","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3920\/BM2015.0065","volume":"6","author":"V Stadlbauer","year":"2015","unstructured":"Stadlbauer, V. Immunosuppression and probiotics: are they effective and safe? Benef. Microbes 6, 823\u2013828 (2015).","journal-title":"Benef. Microbes"},{"key":"1271_CR149","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.biopha.2018.12.104","volume":"111","author":"D Kothari","year":"2019","unstructured":"Kothari, D., Patel, S. & Kim, S.-K. Probiotic supplements might not be universally-effective and safe: a review. Biomed. Pharmacother. 111, 537\u2013547 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"1271_CR150","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/bmt.2015.275","volume":"51","author":"EJ Ladas","year":"2016","unstructured":"Ladas, E. J. et al. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transpl. 51, 262\u2013266 (2016).","journal-title":"Bone Marrow Transpl."},{"key":"1271_CR151","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-092984","volume":"15","author":"SS Nair","year":"2025","unstructured":"Nair, S. S. et al. Microbiota-directed intervention in living donor liver transplant recipients: protocol for a randomised double-blind placebo-controlled trial. BMJ Open\u00a015, e092984 (2025).","journal-title":"BMJ Open"},{"key":"1271_CR152","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen, S. et al. The International Scientific Association of Probiotics And Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. 18, 649\u2013667 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1271_CR153","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.4049\/jimmunol.2000780","volume":"206","author":"O Kalinina","year":"2021","unstructured":"Kalinina, O. et al. Amelioration of graft-versus-host disease by exopolysaccharide from a commensal bacterium. J. Immunol. 206, 2101\u20132108 (2021).","journal-title":"J. Immunol."},{"key":"1271_CR154","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson, N. D. et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat. Immunol. 17, 505\u2013513 (2016).","journal-title":"Nat. Immunol."},{"key":"1271_CR155","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/ajt.15880","volume":"20","author":"W Jiao","year":"2020","unstructured":"Jiao, W. et al. Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota. Am. J. Transpl. 20, 2413\u20132424 (2020).","journal-title":"Am. J. Transpl."},{"key":"1271_CR156","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407\u2013415 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1271_CR157","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218\u20131228 (2017).","journal-title":"Lancet"},{"key":"1271_CR158","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/ecco-jcc\/jjae043","volume":"18","author":"E van Lingen","year":"2024","unstructured":"van Lingen, E. et al. Faecal microbiota transplantation engraftment after budesonide or placebo in patients with active ulcerative colitis using pre-selected donors: a randomized pilot study. J. Crohn Colitis 18, 1381\u20131393 (2024).","journal-title":"J. Crohn Colitis"},{"key":"1271_CR159","doi-asserted-by":"publisher","first-page":"1394379","DOI":"10.1155\/2018\/1394379","volume":"2018","author":"O Shogbesan","year":"2018","unstructured":"Shogbesan, O. et al. A systematic review of the efficacy and safety of fecal microbiota transplant for Clostridium difficile infection in immunocompromised patients. Can. J. Gastroenterol. Hepatol. 2018, 1394379 (2018).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"1271_CR160","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ajt.15058","volume":"19","author":"Y-W Cheng","year":"2019","unstructured":"Cheng, Y.-W. et al. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: a multicenter experience. Am. J. Transpl. 19, 501\u2013511 (2019).","journal-title":"Am. J. Transpl."},{"key":"1271_CR161","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.bbmt.2018.10.022","volume":"25","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp, Z., Hohmann, E., Jenq, R. R. & Chen, Y.-B. Fecal microbiota transplantation: restoring the injured microbiome after allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transpl. 25, e17\u2013e22 (2019).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"1271_CR162","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1158\/1078-0432.CCR-23-2369","volume":"29","author":"A Rashidi","year":"2023","unstructured":"Rashidi, A. et al. Potential of fecal microbiota transplantation to prevent acute GVHD: analysis from a phase II trial. Clin. Cancer Res. 29, 4920\u20134929 (2023). This phase II interventional trial of faecal microbiota transplantation in allogeneic haematopoietic-stem-cell transplantation recipients shows that faecal microbiota transplantation is feasible and safe, and suggests a reduced risk of acute graft-versus-host disease.","journal-title":"Clin. Cancer Res."},{"key":"1271_CR163","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1200\/JCO.22.02366","volume":"41","author":"A Rashidi","year":"2023","unstructured":"Rashidi, A. et al. Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML. J. Clin. Oncol. 41, 5306\u20135319 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1271_CR164","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1158\/2767-9764.CRC-24-0138","volume":"4","author":"A Rashidi","year":"2024","unstructured":"Rashidi, A. et al. Multi-omics analysis of a fecal microbiota transplantation trial identifies novel aspects of acute GVHD pathogenesis. Cancer Res. Commun. 4, 1454\u20131466 (2024). The follow-up multi-omics study to the phase II clinical trial on faecal microbiota transplantation in allogeneic haematopoietic-stem-cell transplantation recipients conducted in ref. 162 provided mechanistic insights, identifying microbial and metabolic shifts linked to graft-versus-host disease pathogenesis.","journal-title":"Cancer Res. Commun."},{"key":"1271_CR165","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068480","volume":"13","author":"A Doug\u00e9","year":"2023","unstructured":"Doug\u00e9, A. et al. Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study). BMJ Open\u00a013, e068480 (2023).","journal-title":"BMJ Open"},{"key":"1271_CR166","doi-asserted-by":"publisher","first-page":"eabo2750","DOI":"10.1126\/scitranslmed.abo2750","volume":"15","author":"MH Woodworth","year":"2023","unstructured":"Woodworth, M. H. et al. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. Sci. Transl. Med. 15, eabo2750 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1271_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0269-3","volume":"5","author":"S Khanna","year":"2017","unstructured":"Khanna, S. et al. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome 5, 55 (2017).","journal-title":"Microbiome"},{"key":"1271_CR168","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s12276-021-00627-6","volume":"53","author":"J-H Kim","year":"2021","unstructured":"Kim, J.-H., Kim, K. & Kim, W. Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy. Exp. Mol. Med. 53, 907\u2013916 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1271_CR169","doi-asserted-by":"publisher","first-page":"eaap9489","DOI":"10.1126\/scitranslmed.aap9489","volume":"10","author":"Y Taur","year":"2018","unstructured":"Taur, Y. et al. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci. Transl. Med. 10, eaap9489 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1271_CR170","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","volume":"2","author":"Z DeFilipp","year":"2018","unstructured":"DeFilipp, Z. et al. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2, 745\u2013753 (2018).","journal-title":"Blood Adv."},{"key":"1271_CR171","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac, C. et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat. Commun. 11, 2168 (2020).","journal-title":"Nat. Commun."},{"key":"1271_CR172","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12876-024-03129-7","volume":"24","author":"M Thing","year":"2024","unstructured":"Thing, M. et al. Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease. BMC Gastroenterol. 24, 43 (2024).","journal-title":"BMC Gastroenterol."},{"key":"1271_CR173","doi-asserted-by":"publisher","unstructured":"Li, Q. et al. Microbial metabolite indole-3-propionic acid drives mitochondrial respiration in CD4+ T cells to confer protection against intestinal inflammation. Nat. Metab. https:\/\/doi.org\/10.1038\/s42255-025-01396-6 (2025).","DOI":"10.1038\/s42255-025-01396-6"},{"key":"1271_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47622-6","volume":"9","author":"A Tuomisto","year":"2019","unstructured":"Tuomisto, A. et al. Serum enterolactone concentrations are low in colon but not in rectal cancer patients. Sci. Rep. 9, 11209 (2019).","journal-title":"Sci. Rep."},{"key":"1271_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13722-4","volume":"7","author":"T Pallister","year":"2017","unstructured":"Pallister, T. et al. Hippurate as a metabolomic marker of gut microbiome diversity: modulation by diet and relationship to metabolic syndrome. Sci. Rep. 7, 13670 (2017).","journal-title":"Sci. Rep."},{"key":"1271_CR176","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41564-021-01030-7","volume":"7","author":"N-N Liu","year":"2022","unstructured":"Liu, N.-N. et al. Multi-kingdom microbiota analyses identify bacterial\u2013fungal interactions and biomarkers of colorectal cancer across cohorts. Nat. Microbiol. 7, 238\u2013250 (2022).","journal-title":"Nat. Microbiol."},{"key":"1271_CR177","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2023-330001","volume":"73","author":"HM Tun","year":"2024","unstructured":"Tun, H. M. et al. Gut virome in inflammatory bowel disease and beyond. Gut 73, 350\u2013360 (2024).","journal-title":"Gut"},{"key":"1271_CR178","doi-asserted-by":"publisher","first-page":"e969","DOI":"10.1016\/S2666-5247(22)00203-8","volume":"3","author":"F Zhang","year":"2022","unstructured":"Zhang, F., Aschenbrenner, D., Yoo, J. Y. & Zuo, T. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. Lancet Microbe 3, e969\u2013e983 (2022).","journal-title":"Lancet Microbe"},{"key":"1271_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18476-8","volume":"11","author":"VK Gupta","year":"2020","unstructured":"Gupta, V. K. et al. A predictive index for health status using species-level gut microbiome profiling. Nat. Commun. 11, 4635 (2020).","journal-title":"Nat. Commun."},{"key":"1271_CR180","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/medicina55100672","volume":"55","author":"S Chan","year":"2019","unstructured":"Chan, S. et al. Infectious complications following kidney transplantation \u2014 a focus on hepatitis C infection, cytomegalovirus infection and novel developments in the gut microbiota. Medicina 55, 672 (2019).","journal-title":"Medicina"},{"key":"1271_CR181","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","volume":"388","author":"J Bola\u00f1os-Meade","year":"2023","unstructured":"Bola\u00f1os-Meade, J. et al. Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N. Engl. J. Med. 388, 2338\u20132348 (2023).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-025-01271-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-025-01271-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-025-01271-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:03:06Z","timestamp":1779192186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-025-01271-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":181,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1038\/s41579-025-01271-x","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"4 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.K.W. acted as a consultant for Takeda; received unrestricted research grants from Takeda, Johnson & Johnson, Tramedico and Ferring; and received speaker fees from MSD, Falk, AbbVie and Janssen Pharmaceuticals. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}